1
|
Hsin JP, Lu Y, Leslie CS, Rudensky AY. Abstract A062: The effects of cellular context on miR-155 mediated regulation of gene expression. Cancer Immunol Res 2016. [DOI: 10.1158/2326-6066.imm2016-a062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
MicroRNA-155 (miR-155) is involved in differentiation and regulation of responses of multiple haematopoietic cell types. Its dysregulation is implicated in many human malignancies, e.g. Hodgkin, diffuse large B lymphomas, and breast cancer. Many microRNAs and their target mRNAs are co-expressed in diverse types of cells and tissues. To what extent the interaction between a specific microRNA and its target mRNAs is preserved in different cellular context is largely unknown. We employed genome-wide approaches to investigate whether regulation of commonly expressed mRNA by miR-155 operates in a cell type-specific manner in analogy to cell-context dependent regulation by transcription factors. We first performed RNA-Seq to quantitatively measure mRNA expression levels in primary B cells, dendritic cells, macrophages, and CD4+ T cells from wild type and miR-155 knockout mice. We found many miR-155 target mRNAs that contain seed matches in 3' untranslated regions (3'UTRs) were differentially repressed between four types of primary immune cells. Next, we performed iCLIP (individual-nucleotide resolution UV crosslinking and immunoprecipitation) to precisely map Argonaute 2 binding. Quantitative analysis of iCLIP in both wild type and miR-155 KO primary cells uncovered hundreds of miR-155 bound genes, a large number of which overlapped the cohorts of genes that were identified by RNA-Seq as differentially regulated by miR-155. Most mRNAs are alternatively polyadenylated, and through alternative polyadenylation (ApA) mRNAs can acquire or lose microRNA sites. To account for ApA, we carried out PolyA-Seq to measure polyadenylation site usage, and found that ApA contributed to differential miR-155 regulation of a number of genes. However, in many cases the same target 3'UTR isoforms were differentially regulated between cell types, suggesting ApA-independent mechanisms of miR-155 specificity, and cellular context dependent miR-155-mediated regulation of gene expression. This research will elucidate mechanistic underpinning of cell-context dependent microRNA function, and help understand miR-155 functions in disease, specifically in lymphomas and other cancers.
Citation Format: Jing-Ping Hsin, Yuheng Lu, Christina S. Leslie, Alexander Y. Rudensky. The effects of cellular context on miR-155 mediated regulation of gene expression [abstract]. In: Proceedings of the Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; 2016 Sept 25-28; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2016;4(11 Suppl):Abstract nr A062.
Collapse
Affiliation(s)
- Jing-Ping Hsin
- 1Immunology Program, Sloan Kettering Institute, New York, NY
| | - Yuheng Lu
- 2Computational Biology Program, Sloan Kettering Institute, New York, NY
| | | | | |
Collapse
|
2
|
Lu LF, Gasteiger G, Yu IS, Chaudhry A, Hsin JP, Lu Y, Bos PD, Lin LL, Zawislak CL, Cho S, Sun JC, Leslie CS, Lin SW, Rudensky AY. A Single miRNA-mRNA Interaction Affects the Immune Response in a Context- and Cell-Type-Specific Manner. Immunity 2015; 43:52-64. [PMID: 26163372 DOI: 10.1016/j.immuni.2015.04.022] [Citation(s) in RCA: 140] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2014] [Revised: 04/23/2015] [Accepted: 04/28/2015] [Indexed: 10/23/2022]
Abstract
MicroRNA (miRNA)-dependent regulation of gene expression confers robustness to cellular phenotypes and controls responses to extracellular stimuli. Although a single miRNA can regulate expression of hundreds of target genes, it is unclear whether any of its distinct biological functions can be due to the regulation of a single target. To explore in vivo the function of a single miRNA-mRNA interaction, we mutated the 3' UTR of a major miR-155 target (SOCS1) to specifically disrupt its regulation by miR-155. We found that under physiologic conditions and during autoimmune inflammation or viral infection, some immunological functions of miR-155 were fully or largely attributable to the regulation of SOCS1, whereas others could be accounted only partially or not at all by this interaction. Our data suggest that the role of a single miRNA-mRNA interaction is dependent on cell type and biological context.
Collapse
Affiliation(s)
- Li-Fan Lu
- Howard Hughes Medical Institute and Immunology Program, and Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Division of Biological Sciences and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA
| | - Georg Gasteiger
- Howard Hughes Medical Institute and Immunology Program, and Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Institute of Medical Microbiology and Hygiene, University of Mainz Medical Centre, Mainz 55131, Germany
| | - I-Shing Yu
- Laboratory Animal Center, College of Medicine, National Taiwan University, Taipei 100, Taiwan
| | - Ashutosh Chaudhry
- Howard Hughes Medical Institute and Immunology Program, and Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
| | - Jing-Ping Hsin
- Howard Hughes Medical Institute and Immunology Program, and Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
| | - Yuheng Lu
- Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
| | - Paula D Bos
- Howard Hughes Medical Institute and Immunology Program, and Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
| | - Ling-Li Lin
- Howard Hughes Medical Institute and Immunology Program, and Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Division of Biological Sciences and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA
| | - Carolyn L Zawislak
- Howard Hughes Medical Institute and Immunology Program, and Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
| | - Sunglim Cho
- Division of Biological Sciences and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA
| | - Joseph C Sun
- Howard Hughes Medical Institute and Immunology Program, and Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
| | - Christina S Leslie
- Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA
| | - Shu-Wha Lin
- Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 100, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei 100, Taiwan
| | - Alexander Y Rudensky
- Howard Hughes Medical Institute and Immunology Program, and Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
| |
Collapse
|
3
|
Abstract
The RNA polymerase II largest subunit (Rpb1) contains a unique C-terminal domain (CTD) that plays multiple roles during transcription. The CTD is composed of consensus Y1S2P3T4S5P6S7 repeats, in which Ser, Thr and Tyr residues can all be phosphorylated. Here we report analysis of CTD Tyr1 using genetically tractable chicken DT40 cells. Cells expressing an Rpb1 derivative with all Tyr residues mutated to Phe (Rpb1-Y1F) were inviable. Remarkably, Rpb1-Y1F was unstable, degraded to a CTD-less form; however stability, but not cell viability, was fully rescued by restoration of a single C-terminal Tyr (Rpb1-25F+Y). Cytoplasmic and nucleoplasmic Rpb1 was phosphorylated exclusively on Tyr1, and phosphorylation specifically of Tyr1 prevented CTD degradation by the proteasome in vitro. Tyr1 phosphorylation was also detected on chromatin-associated, hyperphosphorylated Rpb1, consistent with a role in transcription. Indeed, we detected accumulation of upstream antisense (ua) RNAs in Rpb1-25F+Y cells, indicating a role for Tyr1 in uaRNA expression. DOI:http://dx.doi.org/10.7554/eLife.02112.001 When a gene is expressed, the DNA is first transcribed to produce an intermediate molecule called a messenger RNA (mRNA), which is then translated to produce a protein. RNA Polymerase II is an enzyme that makes mRNA molecules in organisms as diverse as plants, animals and yeast. RNA Polymerase II is a complex made of a number of proteins. The largest protein in this complex includes a ‘carboxy-terminal domain’ that has multiple repeats of seven amino acids one after the other. The first amino acid in each repeat, a tyrosine, is referred to as tyrosine-1. Adding various chemical tags to the amino acids in these repeats co-ordinates the steps involved in the transcription of genes. In yeast, for example, adding a phosphate groups to tyrosine-1 seems to help the polymerase to proceed to make long mRNA molecules. However, it is not known what these chemical tags do in humans or other animals. Now Hsin et al. (and independently Descostes, Heidemann et al.) have shown that the same phosphate groups on tyrosine-1 perform functions in vertebrates (animals with backbones) that are different to those performed in yeast. These functions include protecting the carboxy-terminal domain from being broken down inside cells, and transcribing the DNA that is upstream of genes. Hsin et al. replaced tyrosine-1 in RNA Polymerase II from chicken cells with a related amino acid that cannot have phosphate groups added to it. This mutant RNA Polymerase II was unstable and degraded by the molecular machinery in cells that breaks down damaged or unneeded proteins back into amino acids. Hsin et al. also compared the mRNA molecules that are made by the wild-type RNA Polymerase II with those produced by a related mutant. This comparison revealed an unexpected accumulation of RNA molecules that are transcribed in the opposite direction from mRNAs. These RNA molecules, known as ‘upstream antisense RNAs’, have been described only recently. And while the function of these RNAs remains mysterious, the results of Hsin et al. suggest that tyrosine-1 helps to ensure that these RNA molecules are rapidly broken down. The results of Hsin et al. raise a number of important questions, and foremost among these questions is: how do these newly discovered properties of tyrosine-1 contribute to the control of gene expression in animals? Further work is needed to answer this question. DOI:http://dx.doi.org/10.7554/eLife.02112.002
Collapse
Affiliation(s)
- Jing-Ping Hsin
- Department of Biological Sciences, Columbia University, New York, United States
| | - Wencheng Li
- Department of Biochemistry and Molecular Biology, Rutgers University New Jersey Medical School, Newark, United States
| | - Mainul Hoque
- Department of Biochemistry and Molecular Biology, Rutgers University New Jersey Medical School, Newark, United States
| | - Bin Tian
- Department of Biochemistry and Molecular Biology, Rutgers University New Jersey Medical School, Newark, United States
| | - James L Manley
- Department of Biological Sciences, Columbia University, New York, United States
| |
Collapse
|
4
|
Abstract
The C-terminal domain (CTD) of the RNA polymerase II largest subunit consists of multiple heptad repeats (consensus Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7), varying in number from 26 in yeast to 52 in vertebrates. The CTD functions to help couple transcription and processing of the nascent RNA and also plays roles in transcription elongation and termination. The CTD is subject to extensive post-translational modification, most notably phosphorylation, during the transcription cycle, which modulates its activities in the above processes. Therefore, understanding the nature of CTD modifications, including how they function and how they are regulated, is essential to understanding the mechanisms that control gene expression. While the significance of phosphorylation of Ser2 and Ser5 residues has been studied and appreciated for some time, several additional modifications have more recently been added to the CTD repertoire, and insight into their function has begun to emerge. Here, we review findings regarding modification and function of the CTD, highlighting the important role this unique domain plays in coordinating gene activity.
Collapse
Affiliation(s)
- Jing-Ping Hsin
- Department of Biological Sciences, Columbia University, New York, New York 10027, USA
| | | |
Collapse
|
5
|
Abstract
The RNA polymerase II (RNAP II) largest subunit contains a C-terminal domain (CTD) with up to 52 Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7) consensus repeats. Serines 2, 5, and 7 are known to be phosphorylated, and these modifications help to orchestrate the interplay between transcription and processing of messenger RNA (mRNA) precursors. Here, we provide evidence that phosphorylation of CTD Thr(4) residues is required specifically for histone mRNA 3' end processing, functioning to facilitate recruitment of 3' processing factors to histone genes. Like Ser(2), Thr(4) phosphorylation requires the CTD kinase CDK9 and is evolutionarily conserved from yeast to human. Our data thus illustrate how a CTD modification can play a highly specific role in facilitating efficient gene expression.
Collapse
Affiliation(s)
- Jing-Ping Hsin
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA
| | | | | |
Collapse
|
6
|
Abstract
We have identified a novel p53 regulated gene designated DDA3 through differential mRNA display on IW32 erythroleukemia cells containing a temperature sensitive p53 allele, tsp53val-135. DDA3 mRNA induction could be observed in all sublines expressing tsp53val-135 cultured at permissive temperature as well as in NIH3T3 cells undergoing DNA damage. Upregulation of DDA3 could be detected within 2 h after down-shifting the temperature to 32.5 degrees C; upon shifting back to 38.5 degrees C, DDA3 mRNA rapidly degraded with a half-life of less than 2 h. Actinomycin D, but not cycloheximide, inhibited the p53 dependent DDA3 induction, suggesting that the activation is through transcriptional regulation and does not require de novo protein synthesis. DDA3 was expressed in multiple mouse tissues including brain, spleen, lung, kidney and testis. Full-length DDA3 cDNA was cloned and it contained an open reading frame predicted to encode a proline rich protein of 329 amino acids. Overexpression of DDA3 in H1299 lung carcinoma cells suppressed colony formation. These results suggest that DDA3 is a p53-regulated gene that might participate in the p53-mediated growth suppression.
Collapse
Affiliation(s)
- P K Lo
- Institute of Biochemistry, National Yang Ming University, Shih-Pai, Taipei, Taiwan 112, Republic of China
| | | | | | | | | | | | | |
Collapse
|
7
|
Chuang CC, Tan SK, Tai LK, Hsin JP, Wang FF. Evidence for the involvement of protein kinase C in the inhibition of prolactin gene expression by transforming growth factor-beta2. Mol Pharmacol 1998; 53:1054-61. [PMID: 9614208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
We investigated the mechanisms by which transforming growth factor (TGF)-beta2 inhibited prolactin mRNA expression in GH3 rat pituitary tumor cells. Maximal inhibition was observed with cells exposed to 5 ng/ml TGF-beta2 for 24 hr. Continuous presence of the hormone during the entire period was not necessary because exposure of cells to TGF-beta2 for 20 min was sufficient to trigger the same extent of prolactin mRNA inhibition at 24 hr as with its persistent presence. The action of TGF-beta2 could be abolished by cycloheximide or EGTA, suggesting the requirement of a newly synthesized protein and extracellular Ca2+. The response of prolactin mRNA to TGF-beta2 was inhibited by preincubation of cells with phorbol-12-myristate-13-acetate, which down-regulated protein kinase C (PKC). The activities of both the cytosolic and membrane PKC were significantly reduced at 20 min after TGF-beta2 addition, and inhibition continued to 24 hr, the last time point analyzed. However, the ratio of cytosolic to membrane PKC was not altered by TGF-beta2. Inhibition of PKC did not require the sustained presence of TGF-beta2. In vitro kinase assays of the immunoprecipitated PKC demonstrated that the activities of alpha, epsilon, mu, and zeta isozymes were significantly decreased in the TGF-beta2-treated cells, whereas that of PKClambda was not affected. Western blotting did not reveal any change in PKCepsilon steady state protein levels, suggesting TGF-beta2 inhibits PKC activity through a post-translational mechanism. Our results support that inhibition of PKC activity is an early event mediating TGF-beta2-inhibited prolactin mRNA expression in GH3 cells.
Collapse
Affiliation(s)
- C C Chuang
- Institute of Biochemistry, National Yang-Ming University, Shih-Pai, Taipei, Taiwan 11221
| | | | | | | | | |
Collapse
|